Investors

Partnering With Saiiv

Transform Health Monitoring With Us

Partner with Saiiv Monitoring Solutions and be part of a transformative journey in health monitoring. Our AI-powered, non-invasive technologies address the growing burden of chronic cardiovascular/cardiometabolic and cardiorespiratory diseases, offering a unique investment opportunity in an innovative and scalable healthcare solution

Vision and market opportunity

How We're Solving The Gaps In The Market

The global burden of chronic diseases is rapidly increasing, creating a critical need for innovative, cost-effective, and patient-centric solutions.

Saiiv’s vision is to reduce healthcare costs and improve patient outcomes by delivering precision health monitoring tools that integrate advanced technology, AI analysis, and connected care.

Why invest in saiiv?

What Makes Us A Reliable And Worthwhile Investiment Opportunity

Unique Technology

Non-invasive monitoring of heart function and risk assessment using AI-powered algorithms.

Scalable Solutions

Our SMART apps and integrated Bluetooth devices address screening, diagnosis, and care management.

Growing Market

Significant global demand for solutions targeting heart failure, metabolic diseases, and multimorbidity management.

Financial Sustainability

Designed to align with existing healthcare models, Saiiv’s solutions provide cost-effective care that reduces unnecessary expenses for patients, clinicians, and insurers, accelerating adoption and ROI for stakeholders.

Strong Pipeline

Upcoming product launches in 2025, including SMART apps and third-party Bluetooth integrations.

Quadruple Aims

Advancing patient care, enhancing clinician satisfaction, improving population health, and reducing healthcare costs.

Why invest in saiiv?

What Makes Us A Reliable And Worthwhile Investiment Opportunity

Unique Technology

Non-invasive monitoring of heart function and risk assessment using AI-powered algorithms.

Scalable Solutions

Our SMART apps and integrated Bluetooth devices address screening, diagnosis, and care management.

Growing Market

Significant global demand for solutions targeting heart failure, metabolic diseases, and multimorbidity management.

Financial Sustainability

Designed to align with existing healthcare models, Saiiv’s solutions provide cost-effective care that reduces unnecessary expenses for patients, clinicians, and insurers, accelerating adoption and ROI for stakeholders.

Strong Pipeline

Upcoming product launches in 2025, including SMART apps and third-party Bluetooth integrations.

Quadruple Aims

Advancing patient care, enhancing clinician satisfaction, improving population health, and reducing healthcare costs.

Invest in saiiv

Join Us in Transforming Multimorbidity Care

Saiiv is solving one of healthcare’s most urgent and overlooked challenges – multimorbidities. Our end-to-end monitoring system is designed for real-world adoption, combining AI-powered detection, connected devices, and clinician-driven insights to revolutionise how chronic diseases are managed.

We’re inviting investors to be part of this transformation – supporting clinical validation, scaling groundbreaking technology, and shaping the future of proactive healthcare.

Join us in scaling AI-driven, multimorbidity-focused healthcare solutions that will transform patient outcomes.

Investment Portal

As an investor, you’ll also gain exclusive insights into Saiiv’s progress through our secure Investment Portal via Wholesale Investors CapitalHQ portal.

Exclusive updates

Stay informed with product milestones, clinical trial progress, and strategic partnerships.

Presentations

Access in-depth market trends, KPIs, and company strategy presentations.

Investment Materials

Get exclusive quarterly reports, financial forecasts, and case studies.

Current Success and milestones

Our Journey of Achievements and Progress

Grant Programs

Current grant programs underway:

  • NSSN Grand Challenge
  • NSW MVP Ventures for advancing sensor technology.
  • European Union – NextGeneration grant – €900,000
  • Completion of 50 patient trial at two of Australia’s leading heart failure hospitals: The Alfred in Melbourne and St Vincents in Sydney
  • Trial in Italy underway to validate our new Saiiv PulsePoint device against echo in 200 patients with heart disease
  • Future: Further validation of our SMART apps, Bluetooth devices, and advanced sensor systems – Saiiv PulsePoint: and Saiiv LifeBand .
  • Key milestones include a currently estimated product launch of SMART and SMART PLUS apps in 2026.

Collaborations with research groups, clinicians, and global health organizations for clinical trials.

Get in touch

Saiiv is defining the future of monitoring solutions and early detection. Join us.

To learn more about investment opportunities, connect with us directly.